Cargando…
Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
Prostate cancer (PCa) is a carcinoma in which fatty acids are abundant. Fatty acid metabolism is rewired during PCa development. Although PCa can be treated with hormone therapy, after prolonged treatment, castration-resistant prostate cancer can develop and can lead to increased mortality. Changes...
Autores principales: | Xu, Huan, Chen, Yanbo, Gu, Meng, Liu, Chong, Chen, Qi, Zhan, Ming, Wang, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618281/ https://www.ncbi.nlm.nih.gov/pubmed/34822423 http://dx.doi.org/10.3390/metabo11110765 |
Ejemplares similares
-
Exploration of diagnostic biomarkers, microenvironment characteristics, and ursolic acid's therapeutic effect for benign prostate hyperplasia
por: Chen, Yanbo, et al.
Publicado: (2023) -
The function of oxytocin: a potential biomarker for prostate cancer diagnosis and promoter of prostate cancer
por: Xu, Huan, et al.
Publicado: (2017) -
Reprogramming of fatty acid metabolism in cancer
por: Koundouros, Nikos, et al.
Publicado: (2019) -
LncRNA DIO3OS regulated by TGF-β1 and resveratrol enhances epithelial mesenchymal transition of benign prostatic hyperplasia epithelial cells and proliferation of prostate stromal cells
por: Chen, Yanbo, et al.
Publicado: (2021) -
Therapeutic Effects of 25-Hydroxyvitamin D on the Pathological Process of Benign Prostatic Hyperplasia: An In Vitro Evidence
por: Chen, Yanbo, et al.
Publicado: (2021)